A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease

Clinical trial NCT07328451 · RECRUITING

Trial details

NCT number: NCT07328451
Sponsor: Denali Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset

Start date: 2026-01-30
Primary completion: 2027-02-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.